Differently, megalin levels were reduced in the placenta from GDM patients compared to controls (p < 0.05), an alteration prevented by the maternal diet supplemented with EVOO (p < 0.05 GDM-EVOO vs. GDM) (Figures 6C, D). The gene discussed is LRP2; the disease is gestational diabetes.